Acetaminophen Nephrotoxicity in CD-1 Mice: I. Evidence of a Role for in Situ Activation in Selective Covalent Binding and Toxicity

doi:10.1006/taap.1994.1116

Toxicology and Applied Pharmacology

Volume 126, Issue 2, June 1994, Pages 267-275

https://doi.org/10.1006/taap.1994.1116 Get rights and content

Abstract

Acetaminophen (APAP) administration (600 mg/kg, ip) to 18-hr-fasted, 3-month-old male CD-1 mice results in necrosis of the renal convoluted proximal tubules. To selectively inhibit APAP activation in the kidney but not in the liver, 10-week-old male CD-1 mice were castrated under ether anesthesia and allowed to recover for a minimum of 2 weeks before use. Microsomal activation of APAP in vitro was monitored by trapping the APAP-derived electrophile as an N-acetylcysteine conjugate. Production of the conjugate was significantly decreased in renal microsomes from castrated mice. By contrast, hepatic microsomal production of the APAP conjugate was not changed by castration. Castration also did not alter APAP covalent binding in liver or APAP hepatotoxicity. Also, the overall metabolism of APAP was not altered by castration, as there were no significant differences in the 24-hr excretion of APAP urinary metabolites between castrated and sham-operated mice. However, castration did significantly protect mice against APAP nephrotoxicity, as evidenced by decreases in plasma urea nitrogen levels and in the severity of histopathologic damage assessed 12 hr after APAP. Castration also reduced the level of selective covalent binding of APAP metabolites to renal proteins as detected on Western blots with affinity-purified anti-APAP antibodies. These findings suggest that, for the mouse, intrarenal biotransformation of APAP to a reactive electrophile significantly contributes to the APAP covalent binding within the kidney and the subsequent nephrotoxicity.

References (0)

Cited by (87)

Lack of mitochondrial Cyp2E1 drives acetaminophen-induced ER stress-mediated apoptosis in mouse and human kidneys: Inhibition by 4-methylpyrazole but not N-acetylcysteine
2023, Toxicology
Acetaminophen (APAP) overdose causes liver injury and acute liver failure, as well as acute kidney injury, which is not prevented by the clinical antidote N-acetyl-L-cysteine (NAC). The absence of therapeutics targeting APAP-induced nephrotoxicity is due to gaps in understanding the mechanisms of renal injury. APAP metabolism through Cyp2E1 drives cell death in both the liver and kidney. We demonstrate that Cyp2E1 is localized to the proximal tubular cells in mouse and human kidneys. Virtually all the Cyp2E1 in kidney cells is in the endoplasmic reticulum (ER), not in mitochondria. By contrast, hepatic Cyp2E1 is in both the ER and mitochondria of hepatocytes. Consistent with this subcellular localization, a dose of 600 mg/kg APAP in fasted C57BL/6J mice induced the formation of APAP protein adducts predominantly in mitochondria of hepatocytes, but the ER of the proximal tubular cells of the kidney. We found that reactive metabolite formation triggered ER stress-mediated activation of caspase-12 and apoptotic cell death in the kidney. While co-treatment with 4-methylpyrazole (4MP; fomepizole) or the caspase inhibitor Ac-DEVD-CHO prevented APAP-induced cleavage of procaspase-12 and apoptosis in the kidney, treatment with NAC had no effect. These mechanisms are clinically relevant because 4MP but not NAC also significantly attenuated APAP-induced apoptotic cell death in primary human kidney cells. We conclude that reactive metabolite formation by Cyp2E1 in the ER results in sustained ER stress that causes activation of procaspase-12, triggering apoptosis of proximal tubular cells, and that 4MP but not NAC may be an effective antidote against APAP-induced kidney injury.
Mitochondrial versus microsomal bioactivation of paracetamol by human liver and kidney tissues
2022, Toxicology Letters
Citation Excerpt :
PAR-induced renal toxicity occurs in the absence of a significant liver toxicity, even in the hepatectomised mice given PAR. In addition, renal protein covalent binding was also observed in-situ (Hart et al., 1994, 1995). Taken together, these data strongly suggested that NAPQI is not transferred from the liver, instead it is formed locally in the kidney.
Mitochondria appeared to be a major target for paracetamol (PAR)-induced hepatotoxicity. Studies suggested that microsomal CYPs catalyse bioactivation of PAR to N-acetyl-p-benzoquinone imine (NAPQI), which alkylates mitochondrial proteins, and causes transmission of death signal from mitochondria to nucleus. We hypothesised that local formation of NAPQI within mitochondria seems more likely compared to the translocation of NAPQI. We therefore tested whether the formation of NAPQI may be catalysed by mitochondrial CYPs. Cellular fractions were isolated from human liver and kidney to compare the metabolic capacities. Liver and kidney mitochondria are capable to generate NAPQI. Mitochondrial CYP2E1 and CYP3A4 activities were comparable to the microsomal counterparts in both organs. Previously reported higher kidney microsomal CYP2E1 activity in men compared women were observed in mitochondrial CYP2E1 as well in the present study. On the other hand, no correlation between kidney CYP2E1 activity and quantity of NAPQI formation, as well as no induction on mitochondrial permeability transition pore (mPTP) opening by PAR in kidney mitochondria strongly suggested a different toxicity mechanism in this organ.
Part I. Mechanisms of actions and metabolism of acetaminophen related to the neonatal brain
2021, Early Human Development
4-methylpyrazole protects against acetaminophen-induced acute kidney injury
2020, Toxicology and Applied Pharmacology
Citation Excerpt :
Previous data showed that human proximal tubular cells express cytochrome P450 enzymes (Cummings et al., 2000). In addition, APAP undergoes a P450-mediated metabolism, which results in NAPQI formation, GSH depletion and protein binding in the kidney (Emeigh Hart et al., 1991; Hart et al., 1994, 1995). Immunohistochemistry studies have also demonstrated positive staining with both anti-APAP and anti-CYP2E1 antibodies in renal proximal tubules (Hart et al., 1995).
Acetaminophen (APAP) hepatotoxicity is the most common cause of acute liver failure in the United States, and while a significant percentage of APAP overdose patients develop kidney injury, molecular mechanisms involved in APAP-induced nephrotoxicity are relatively unknown. We have shown that 4-methylpyrazole (4MP, Fomepizole) protects against APAP-induced liver injury by inhibiting reactive metabolite formation through Cyp2E1, and analysis of data from APAP overdose patients indicated that kidney dysfunction strongly correlated with severe liver injury. Since Cyp2E1 is also expressed in the kidney, this study explored protection by 4MP against APAP-induced nephrotoxicity. Male C57BL/6 J mice were treated with either 300 or 600 mg/kg APAP with or without 4MP for 2, 6 or 24 h, followed by measurement of APAP metabolism and tissue injury. Interestingly, levels of APAP and its non-oxidative metabolites were significantly higher in kidneys when compared to the liver. APAP-protein adducts were present in both tissues within 2 h, but were absent in kidney mitochondria, unlike in the liver. While GSH depletion was seen in both tissues, activation of c-jun N-terminal kinase and its translocation to the mitochondria, which is a critical feature of APAP-induced liver injury, was not detected in the kidney. Treatment with 4MP attenuated APAP oxidative metabolite generation, GSH depletion as well as kidney injury indicating its potential use in protection against APAP-induced nephrotoxicity. In conclusion, since reactive metabolite formation seems to be common in both liver and kidney, 4MP mediated inhibition of Cyp2E1 protects against APAP-induced nephrotoxicity. However, downstream mechanisms of APAP-induced nephrotoxicity seem distinct from the liver.
Mechanisms of Toxicant-Induced Acute Kidney Injury
2018, Comprehensive Toxicology: Third Edition
This article describes mechanisms of toxicant-induced acute renal failure with an emphasis on the role of renal cell death. Mechanisms explaining why renal cells are susceptible to toxicant-induced injury are initially covered followed by a description of general responses of renal cells to toxicant exposures. The mechanisms of necrosis, apoptosis, and autophagy are discussed. The majority of the article discusses the role of cellular and biochemical mediators in the mechanisms of nephrotoxicity. Cellular targets of nephrotoxicity discussed include organelles such as the plasma membrane, mitochondria, endoplasmic reticulum, and the nucleus. Biochemical mediators of nephrotoxicity discussed include membrane transporters, cytochrome P-450 monooxygenases, reactive oxygen species, proteases, phospholipases, Ca^2 +, and epigenetic-mediated mechanisms. The final section of the article describes general experimental strategies for determining the mechanism of nephrotoxicity. Specific nephrotoxicants discussed include cisplatin, trichloroethylene, and some of its key metabolites, aminoglycosides, HgCl₂, cephaloridine, and model oxidants. Further, when appropriate, mechanisms of ischemia/reperfusion-, hypoxia-, and infection-based insult are discussed for comparison purposes.
Spatial analysis of renal acetaminophen metabolism and its modulation by 4-methylpyrazole with DESI mass spectrometry imaging
2024, Toxicological Sciences

View all citing articles on Scopus

View full text

Regular ArticleAcetaminophen Nephrotoxicity in CD-1 Mice: I. Evidence of a Role for in Situ Activation in Selective Covalent Binding and Toxicity

Abstract

Regular Article
Acetaminophen Nephrotoxicity in CD-1 Mice: I. Evidence of a Role for in Situ Activation in Selective Covalent Binding and Toxicity